Yes, it's new and there will be setbacks. There will be new methods and pathways moving forward, but I don't think that will stop the development of this technology, just like how the Cytokine Release Syndrome didn't stop the development of CAR-T.
My argument stands, if CHM's product is successful down the line when that time comes, there would be better therapies with better efficacy and technology in the market so tell me what would be the point of CHM's products?
Yes, it's new and there will be setbacks. There will be new...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 419507 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18587873 | 22 |
View Market Depth
| Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |